Palisade Asset Management LLC Has $9.79 Million Holdings in Colgate-Palmolive (NYSE:CL)

Palisade Asset Management LLC raised its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 5.8% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 122,804 shares of the company’s stock after acquiring an additional 6,772 shares during the period. Palisade Asset Management LLC’s holdings in Colgate-Palmolive were worth $9,789,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. OFI Invest Asset Management bought a new stake in shares of Colgate-Palmolive during the third quarter valued at approximately $25,000. Avion Wealth raised its position in shares of Colgate-Palmolive by 78.1% during the fourth quarter. Avion Wealth now owns 399 shares of the company’s stock worth $32,000 after acquiring an additional 175 shares during the last quarter. McGlone Suttner Wealth Management Inc. acquired a new position in shares of Colgate-Palmolive during the fourth quarter valued at $34,000. Kayne Anderson Rudnick Investment Management LLC boosted its holdings in Colgate-Palmolive by 142.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 496 shares of the company’s stock valued at $35,000 after acquiring an additional 291 shares during the last quarter. Finally, West Branch Capital LLC increased its position in Colgate-Palmolive by 24.0% in the fourth quarter. West Branch Capital LLC now owns 682 shares of the company’s stock worth $54,000 after purchasing an additional 132 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Noel R. Wallace sold 69,948 shares of the stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the completion of the transaction, the chief executive officer now owns 286,881 shares in the company, valued at $24,161,117.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other Colgate-Palmolive news, CEO Noel R. Wallace sold 69,948 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $84.22, for a total transaction of $5,891,020.56. Following the transaction, the chief executive officer now owns 286,881 shares of the company’s stock, valued at approximately $24,161,117.82. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Noel R. Wallace sold 50,000 shares of the company’s stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the sale, the chief executive officer now owns 274,179 shares in the company, valued at approximately $22,797,983.85. The disclosure for this sale can be found here. Insiders have sold 159,048 shares of company stock worth $13,336,846 over the last ninety days. Insiders own 0.34% of the company’s stock.

Analysts Set New Price Targets

CL has been the topic of several recent research reports. Morgan Stanley raised their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research note on Monday, January 29th. Bank of America upped their target price on shares of Colgate-Palmolive from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Monday, April 29th. Citigroup upped their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a report on Tuesday, April 16th. Raymond James upgraded Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 target price on the stock in a report on Monday, January 29th. Finally, Royal Bank of Canada boosted their target price on Colgate-Palmolive from $88.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Monday, April 29th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $91.44.

View Our Latest Stock Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.6 %

CL traded down $0.61 during trading on Wednesday, hitting $93.47. The company had a trading volume of 7,224,209 shares, compared to its average volume of 4,672,649. The firm’s 50-day moving average price is $88.64 and its 200 day moving average price is $82.63. The company has a market capitalization of $76.69 billion, a PE ratio of 29.77, a PEG ratio of 3.43 and a beta of 0.40. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. Colgate-Palmolive has a one year low of $67.62 and a one year high of $94.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. Colgate-Palmolive had a return on equity of 485.40% and a net margin of 13.22%. The company had revenue of $5.07 billion during the quarter, compared to analysts’ expectations of $4.96 billion. During the same period in the prior year, the firm earned $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 6.2% compared to the same quarter last year. As a group, equities analysts expect that Colgate-Palmolive will post 3.52 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.